08:00 , Jan 4, 2016 |  BioCentury  |  Emerging Company Profile

Regrowing hearing

Acousia Therapeutics GmbH is developing small molecules to treat sensorineural hearing loss that could lead to better speech perception than a clinical-stage gene therapy that also aims to regenerate hair cells. With an investment from...
08:00 , Feb 27, 2012 |  BC Week In Review  |  Clinical News

Autologous umbilical cord blood: Phase I started

Cord Blood Registry began an open-label, U.S. Phase I trial to evaluate a single dose of 6 million cells/kg intravenous autologous umbilical cord blood stem cells in 10 children ages 6 weeks to 18 months...
08:00 , Feb 27, 2012 |  BC Week In Review  |  Clinical News

Autologous umbilical cord blood: Phase I/II started

Cord Blood Registry began a double-blind, placebo-controlled, U.S. Phase I/II trial to evaluate red-cell depleted, infused mononuclear cell enriched umbilical cord blood stem cells in 40 children ages 2-12 with cerebral palsy who do not...